HomeCompanies › CGEN

Compugen

Most recent annual filing: 2026-03-02

Pipeline (7 active programs)

Technology platforms

Unigen

AI/ML powered computational drug target discovery platform using multi-omics datasets, genomics, single-cell RNA sequencing, proteomics and spatial transcriptomics to identify novel immuno-oncology drug targets for cancer immunotherapy

Biotech Distilled coverage (1)

Articles open on Substack. Some deep dives are subscriber-only.